Souleymane Sidibé
Datos Biográficos
| ID | 7015766 |
|---|---|
| NOMBRE | Souleymane Sidibé |
| NOMBRES | Souleymane |
| APELLIDO | Sidibé |
| FIRMA | SIDIBÉ S |
| AFILIACIONES | Helen Keller International |
| VERIFICADO | No |
| TOTAL DE OBRAS | 3 |
| TOTAL DE CITAS | 0 |
| TOTAL COMO AUTOR | 3 |
| TOTAL COMO EDITOR | 0 |
| PRIMER AÑO DE PUBLICACIÓN | 2016 |
| AÑO MÁS RECIENTE DE PUBLICACIÓN | 2026 |
| ÍNDICE H | 0 |
Integration of azithromycin mass administration to 1–11-month-old children into an existing health platform to reduce child mortality
BACKGROUND: Azithromycin mass drug administration (MDA) to ages 1-59 months can reduce childhood mortality; however, more evidence is needed to support targeting a narrower age range of 1-11 months. This trial assesses the efficacy of azithromycin MDA to 1-11-month-old children in reducing mortality in a real-world setting with integration of vitamin A delivery within the established Child Health Days platform in Burkina Faso. METHODS: Mortalite …
Barriers to the diagnosis and treatment of tuberculosis in Abidjan, Côte d’Ivoire
Tuberculosis (TB) remains a leading cause of morbidity and mortality in West Africa. An understanding of the barriers to prompt diagnosis and treatment of TB is critical in order to develop strategies to improve TB outcomes. We conducted a qualitative sub-study within the TB-Sentinel Research Network of IeDEA at the CePReF clinic in Abidjan, Côte d’Ivoire. Individuals $$\:\ge\:$$18 years of age who had received treatment for pulmonary TB within t…
Prevalence and risk factors associated with HIV and tuberculosis in people who use drugs in Abidjan, Ivory Coast
Sin obras prominentes en esta página.
Prevalence and risk factors associated with HIV and tuberculosis in people who use drugs in Abidjan, Ivory Coast
Integration of azithromycin mass administration to 1–11-month-old children into an existing health platform to reduce child mortality
BACKGROUND: Azithromycin mass drug administration (MDA) to ages 1-59 months can reduce childhood mortality; however, more evidence is needed to support targeting a narrower age range of 1-11 months. This trial assesses the efficacy of azithromycin MDA to 1-11-month-old children in reducing mortality in a real-world setting with integration of vitamin A delivery within the established Child Health Days platform in Burkina Faso. METHODS: Mortalite …
Barriers to the diagnosis and treatment of tuberculosis in Abidjan, Côte d’Ivoire
Tuberculosis (TB) remains a leading cause of morbidity and mortality in West Africa. An understanding of the barriers to prompt diagnosis and treatment of TB is critical in order to develop strategies to improve TB outcomes. We conducted a qualitative sub-study within the TB-Sentinel Research Network of IeDEA at the CePReF clinic in Abidjan, Côte d’Ivoire. Individuals $$\:\ge\:$$18 years of age who had received treatment for pulmonary TB within t…
Public health (2 obras) · Tuberculosis (2 obras) · Azithromycin (1 obras) · Biostatistics (1 obras) · Child health (1 obras) · Child Nutrition and Water Access (1 obras) · Demography (1 obras) · Demography (1 obras) · Diagnosis and treatment of tuberculosis (1 obras) · Distress (1 obras)